Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial-Reference-Cited by-同舟云学术

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial

Published:2009-01 Issue:5-6 Volume:10 Page:393-404
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Stommel Elijah W.,Cohen Jeffrey A.,Fadul Camilo E.,Cogbill Christopher H.,Graber David J.,Kingman Linda,Mackenzie Todd,Channon Smith Jacqueline Y.,Harris Brent T.

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/17482960802709416

Reference48 articles.

1. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice

2. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam

3. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

4. Neuropathology of ALS: An overview

5. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review;International Journal of Molecular Sciences;2024-02-01

2. Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3;Frontiers in Molecular Neuroscience;2024-01-16

3. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets;MedComm;2023-09-11

4. The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy;Molecular Neurobiology;2023-07-14

5. Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi Yaklaşımları;Hacettepe University Journal of the Faculty of Pharmacy;2023-02-14